Question 1

What is the catalog number for Urokinase plasminogen activator surface Receptor?

Accepted Answer

The catalog number for Urokinase plasminogen activator surface Receptor is 339132.

Question 2

What sizes are available for Urokinase plasminogen activator surface Receptor?

Accepted Answer

Urokinase plasminogen activator surface Receptor is available in the following size(s): 50 µg, 100 µg.

Question 3

How many pack sizes does Urokinase plasminogen activator surface Receptor come in?

Accepted Answer

Urokinase plasminogen activator surface Receptor is available in 2 different pack sizes.

Question 4

Is Urokinase plasminogen activator surface Receptor in stock?

Accepted Answer

Urokinase plasminogen activator surface Receptor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Urokinase plasminogen activator surface Receptor

Product Specifications

Clonality

Available Sizes

Frequently Asked Questions

Explore Other Products

Recombinant CYB5R3 Antibody

Recombinant CYB5R3 Antibody

Recombinant CYB5R3 Antibody

RGS8 (NM_001102450) Human Over-expression Lysate

NR2E1 (NM_003269) Human Over-expression Lysate

Ankrd35 Mouse Gene Knockout Kit (CRISPR)